Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-26T06:58:31.641Z Has data issue: false hasContentIssue false
  • English
  • Français

Acarbose raises serum butyrate in human subjects withimpaired glucose tolerance

Published online by Cambridge University Press:  09 March 2007

Thomas M. S. Wolever  and
Jean-Louis Chiasson
Thomas M. S. Wolever*
Affiliation:
Departments of Nutritional Sciences and Medicine University of Toronto, and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Ontario, Canada
Jean-Louis Chiasson
Affiliation:
Research Centre, Centre Hospitalier de l'Université de Montréal (CHUM), Campus Hôtel-Dieu and Department of Medicine, University of Montreal, Montreal, Quebec, Canada
*
*Corresponding author: Dr Thomas M. S. Wolever, fax +1 416 978 5882, email thomas.wolever@utoronto.ca
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The fermentation of starch in vitro produces a higher proportion of butyrate than the fermentation of most other substrates. The α-glucosidase inhibitor acarbose increases the amount of starch entering the colon, and has been shown to increase faecal butyrate in humans. It is generally considered that colonic butyrate is quantitatively removed by the colonic mucosa and liver and does not appear in peripheral blood. However, studies in animals suggest that a small proportion of colonic butyrate reaches peripheral blood. Thus, we hypothesised that an increase in colonic butyrate production would result in a rise in serum butyrate in human subjects. To test this, subjects with impaired glucose tolerance were randomly treated in a double-blind fashion with placebo (n 11) or acarbose (n 11) (100 mg three times per day). Serum short-chain fatty acid concentrations were measured twelve times over 12 h with subjects eating a standard diet before randomization and after 4 months of therapy. At baseline, 12 h mean serum butyrate concentrations were similar in the placebo and acarbose groups (2·8 (SE 0·7) AND 3·3 (se 0·6) μm, respectively). After 4 months on placebo, mean serum butyrate (2·6 (se 0·5) μm) was no different from baseline. However, after 4 months on acarbose, serum butyrate had increased to 4·2 (se 1·0) μm, a value which differed significantly from both the baseline value in the acarbose group and the treatment value in the placebo group. We conclude that acarbose increased serum butyrate in subjects with impaired glucose tolerance. These results support the hypothesis that increased colonic butyrate production in human subjects can be detected by an increase in serum butyrate.

Keywords

Short-chain fatty acidsColonic fermentation
Type
Research Article
Information
British Journal of Nutrition , Volume 84 , Issue 1 , July 2000 , pp. 57 - 61
Copyright
Copyright © The Nutrition Society 2000

References

Akanji, AO and Hockaday, TDR (1990) Acetate tolerance and the kinetics of acetate utilization in diabetic and non-diabetic subjects. American Journal of Clinical Nutrition 51, 112–118.CrossRefGoogle Scholar
Akanji, AO, Humphreys, S, Thrusfield, V and Hockaday, TDR (1989) The relationship of plasma acetate with glucose and other blood intermediary metabolites in non-diabetic and diabetic subjects. Clinica Chimica Acta 185, 25–34.CrossRefGoogle ScholarPubMed
Ballard, FJ (1972) Supply and utilization of acetate in mammals. American Journal of Clinical Nutrition 25, 773–779.CrossRefGoogle ScholarPubMed
Brindle, PA, Schooley, DA, Tsai, LW and Baker, FC (1988) Comparative metabolism of branched-chain amino acids to precursors of juvenile hormone biogenesis in corpora allata of lepidopterous versus nonlepidopterous insects. Journal of Biological Chemistry 263, 10653–10657.CrossRefGoogle ScholarPubMed
Chiasson, J-L, Josse, RG, Leiter, LA, Mihic, M, Nathan, DM, Palmason, C, Cohen, RM and Wolever, TMS (1996) The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care 19, 1190–1193.CrossRefGoogle ScholarPubMed
Cummings, JH and MacFarlane, GT (1991) The control and consequences of bacterial fermentation in the human colon. Journal of Applied Bacteriology 70, 443–459.CrossRefGoogle ScholarPubMed
Cummings, JH, Pomare, EW, Branch, WJ, Naylor, CPE and MacFarlane, GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227.CrossRefGoogle ScholarPubMed
Englyst, HH, Hay, S and MacFarlane, GT (1987) Polysaccharide breakdown by mixed populations of human faecal bacteria. FEMS Microbiology Ecology 95, 163–171.CrossRefGoogle Scholar
Felber, JP, Ferrannini, E, Golay, A, Meyer, HU, Theibaud, D, Curchod, B, Maeder, E, Jequier, E and DeFronzo RA (1987) Role of lipid oxidation in pathogenesis of insulin resistance in obesity and type II diabetes. Diabetes 36, 1341–1350.CrossRefGoogle ScholarPubMed
Florent, C, Flourie, B, Leblond, A, Rautureau, M, Bernier, J-J and Rambaud, J-C (1985) Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). Journal of Clinical Investigation 75, 608–613.CrossRefGoogle ScholarPubMed
Holt, PR, Atillasoy, E, Lindenbaum, J, Ho, SB, Lupton, JR, McMahon D and Moss, SF (1996) Effects of acarbose on fecal nutrients, colonic pH, and short chain fatty acids and rectal proliferative indices. Metabolism 45, 1179–1187.CrossRefGoogle ScholarPubMed
Jenkins, DJA, Taylor, RH, Goff, DV, Fielden, H, Misiewicz, JJ, Sarson, DL, Bloom, SR and Alberti, KGMM (1981) Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes 30, 951–954.CrossRefGoogle ScholarPubMed
Marchesini, G, Cassarani, S, Checchia, GA, Bianchi, G, Bua, V, Zoli, M and Pisi, E (1987) Insulin resistance in aged man: relationship between impaired glucose tolerance and decreased insulin activity on branched chain amino acids. Metabolism 36, 1096–1100.CrossRefGoogle ScholarPubMed
Nair, KS, Garrow, JS, Ford, C, Mahler, RF and Halliday, D (1983) Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 25, 400–403.CrossRefGoogle ScholarPubMed
Nishina, PM and Freedland, RA (1990) Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. Journal of Nutrition 120, 668–673.CrossRefGoogle ScholarPubMed
Rémésy, C, Demingé, C and Chartier, F (1980) Origin and utilization of volatile fatty acids in the rat. Reproduction Nutrition Dévelopment 20, 1339–1349.CrossRefGoogle ScholarPubMed
Roediger, WEW (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21, 793–798.CrossRefGoogle ScholarPubMed
Scheppach, W, Fabian, C, Sachs, M and Kasper, H (1988) The effect of starch malabsorption on fecal short-chain fatty acid excretion in man. Scandinavian Journal of Gastroenterology 23, 755–759.CrossRefGoogle ScholarPubMed
Scheppach, W, Pomare, WE, Elia, M and Cummings, JH (1991) The contribution of the large intestine to blood acetate in man. Clinical Science 80, 177–182.CrossRefGoogle ScholarPubMed
Skutches, CL, Holroyde, CP, Myers, RN, Paul, P and Reichard, GA (1979) Plasma acetate turnover and oxidation. Journal of Clinical Investigation 64, 708–713.CrossRefGoogle ScholarPubMed
Snedecor, GW & Cochran, WG (1980) Statistical Methods, 7th ed. Ames, IA: Iowa State University Press.Google Scholar
Taylor, RH, Jenkins, DJA, Barker, HM, Fielden, H, Goff, DV, Misiewicz, JJ, Lee, DA, Allen, HB, MacDonald G and Wallrabe, H (1982) Effect of acarbose on the 24-hour blood glucose profile and pattern of carbohydrate absorption. Diabetes Care 5, 92–96.CrossRefGoogle ScholarPubMed
Walter, DJ, Eastwood, MA, Brydon, WG and Elton, RA (1986) An experimental design to study colonic fibre fermentation in the rat: the duration of feeding. British Journal of Nutrition 55, 465–479.CrossRefGoogle ScholarPubMed
Walter, JH, Thompson, GN, Leonard, JV, Heatherington, CS and Bartlett, K (1989) Measurement of propionate turnover in vivo using sodium [2H5] propionate and sodium [13C] propionate. Clinica Chimica Acta 182, 141–150.CrossRefGoogle Scholar
Weaver, GA, Krause, JA, Miller, TL and Wolin, MJ (1992) Cornstarch fermentation by the colonic microbial community yields more butyrate than does cabbage fiber fermentation; cornstarch fermentation rates correlate negatively with methanogenesis. American Journal of Clinical Nutrition 55, 70–77.CrossRefGoogle ScholarPubMed
Weaver, GA, Tangel, CT, Krause, JA, Parfitt, MM, Jenkins, PL, Rader, JM, Lewis, BA, Miller, TL and Wolin, MY (1997) Acarbose enhances colonic butyrate production. Journal of Nutrition 127, 717–723.CrossRefGoogle ScholarPubMed
Wolever, TMS, Fernandes, J and Rao, AV (1996) Serum acetate: propionate ratio is related to serum cholesterol in men but not women. Journal of Nutrition 126, 2790–2797.Google Scholar
Wolever, TMS, Josse, RG, Leiter, LA and Chiasson, J-L (1997) Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 46, 805–811.CrossRefGoogle ScholarPubMed
Wolever, TMS, Spadafora, P and Eshuis, H (1991) Interaction between colonic acetate and propionate in man. American Journal of Clinical Nutrition 53, 681–687.CrossRefGoogle Scholar
Wolever, TMS, Spadafora, PJ, Cunnane, SC and Pencharz, PB (1995) Propionate inhibits incorporation of colonic [1,2-13C] acetate into plasma lipids in humans. American Journal of Clinical Nutrition 61, 1241–1247.CrossRefGoogle ScholarPubMed
Wolever, TMS, ter Wal, P, Spadafora, P and Robb, P (1992) Guar, but not psyllium, increases breath methane and serum acetate concentrations in human subjects. American Journal of Clinical Nutrition 55, 719–722.CrossRefGoogle Scholar